Invasive squamous carcinoma of the vulva in young patients
dc.contributor.author | Choo, Yew Cheong | en_US |
dc.date.accessioned | 2006-04-07T17:53:11Z | |
dc.date.available | 2006-04-07T17:53:11Z | |
dc.date.issued | 1982-04 | en_US |
dc.identifier.citation | Choo, Yew Cheong (1982/04)."Invasive squamous carcinoma of the vulva in young patients." Gynecologic Oncology 13(2): 158-164. <http://hdl.handle.net/2027.42/24017> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WG6-4C52K7P-2R/2/9eaa89df1cae4fc6192c28a65045a31d | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/24017 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7076032&dopt=citation | en_US |
dc.description.abstract | Over a 30-year period, 17 patients below the age of 35 with invasive squamous carcinoma of the vulva were identified, 8 of whom (47.1%) had "microinvasive" disease. Venereal diseases and condyloma accuminata were not predisposing factors. Immunosuppression was a contributory factor in 2 patients. Although carcinoma in situ was antecedent in only 1 patient, it was an associated lesion in 87.5% of patients with "microinvasive" and 22.2% of patients with invasive carcinoma. The nature and course of this disease in young patients do not differ from the elder counterpart. Prolonged follow-up of these patients has revealed increased susceptibility of the perineum, vagina, and cervix to multiple neoplasms. | en_US |
dc.format.extent | 475228 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Invasive squamous carcinoma of the vulva in young patients | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Hospital, Ann Arbor, Michigan 48109, USA | en_US |
dc.identifier.pmid | 7076032 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/24017/1/0000266.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0090-8258(82)90023-3 | en_US |
dc.identifier.source | Gynecologic Oncology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.